Asymmetric Dimethylarginine: A Never-Aging Story
Hormone and Metabolic Research · 01.11.2025 · 57 (11) · 619-625
DOI: 10.1055/a-2537-4692 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.11.2025. Verfasst von Natalia Jarzebska und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: Arginine, Aging. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Human aging is intrinsically associated with the onset and the progression of several disease states causing significant disability and poor quality of life. Although such association was traditionally considered immutable, recent advances have led to a better understanding of several critical biochemical pathways involved in the aging process. This, in turn, has stimulated a significant body of research to investigate whether reprogramming these pathways could delay the progression of human ageing and/or prevent relevant disease states, ultimately favoring healthier aging process. Cellular senescence is regarded as the principal causative factor implicated in biological and pathophysiological processes involved in aging. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase and an independent risk factor for several age-associated diseases. The selective extracorporeal removal of ADMA is emerging as a promising strategy to reduce the burden of age-associated disease states. This article discusses the current knowledge regarding the critical pathways involved in human aging and associated diseases and the possible role of ADMA as a target for therapies leading to healthier aging processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
- School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom of Great Britain and Northern Ireland.
- Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
- Ageing Research at King's (ARK), King's College London, London, United Kingdom of Great Britain and Northern Ireland.
- Department of Physiology, Anatomy and Genetics, Medical Sciences Division, University of Oxford, Oxford, United Kingdom of Great Britain and Northern Ireland.
- Department of Psychology, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Roman N Rodionov
Zitieren
APA
Jarzebska, N., Bornstein, S. R., Tselmin, S., Julius, U., Cellini, B., Siow, R., Martin, M., Mookerjee, R. P., Mangoni, A. A., Weiss, N., & Rodionov, R. N. (2025). Asymmetric Dimethylarginine: A Never-Aging Story. Hormone and Metabolic Research, 57(11), 619-625. https://doi.org/10.1055/a-2537-4692
Vancouver
Jarzebska N, Bornstein SR, Tselmin S, Julius U, Cellini B, Siow R, et al. Asymmetric Dimethylarginine: A Never-Aging Story. Hormone and Metabolic Research. 2025;57(11):619-625. doi:10.1055/a-2537-4692
BibTeX
@article{Jarzebska2025,
author = {Jarzebska, Natalia and Bornstein, Stefan R and Tselmin, Sergey and Julius, Ulrich and Cellini, Barbara and Siow, Richard and Martin, Mike and Mookerjee, Rajeshwar P and Mangoni, Arduino A and Weiss, Norbert and Rodionov, Roman N},
title = {Asymmetric Dimethylarginine: A Never-Aging Story},
journal = {Hormone and Metabolic Research},
year = {2025},
volume = {57},
number = {11},
pages = {619--625},
doi = {10.1055/a-2537-4692}
}
EUVIMED